Tag: TMVI
TMVI is a “reproducible and reliable” tool for eliminating mitral regurgitation
Findings of the CHOIC...
Abbott becomes first company in world to have transcatheter mitral implantation device on market
The Tendyne transcatheter...
TMVI with Tiara valve may be safe and feasible for patients with prior aortic valve replacement
A new study indicates...
ESC 2018: TMVI associated with “excellent outcomes” for valve-in-valve procedures
New results from the ...
Abbott launches trial of its Tendyne transcatheter mitral valve implantation device
Abbott has initiated ...
ICI 2017: Novel transcatheter mitral valve wins Best Technology Parade Presentation
4C Medical Technologies h...
TCT 2017: TMVI in mitral ring is a reasonable alternative for high-risk patients
Data from the MITRAL ...
TCT 2017: Two studies support feasibility of transcatheter mitral valve implantation
Early experiences wit...
Novel mitral regurgitation therapy featured in Innovation Summit at Cardiovascular Innovations
4C Medical Technologies h...
Neovasc receives approval to launch European study of Tiara transcatheter mitral valve
Neovasc has received ...
First-in-human implants of Caisson Interventional’s percutaneous mitral valve device performed
Caisson Interventional ha...
FDA gives Neovasc go-ahead to add 40mm valve size to its TIARA-I clinical trial
The FDA has given...
